top of page

J&J Says Review of Illness That Led to Pause of Coronavirus Vaccine Trial Could Take Days

(Reuters) - Johnson & Johnson said on Tuesday it would take a few days at least to hear from a safety monitoring panel about its review of the company's late-stage COVID-19 vaccine trial after announcing that the large study had been paused due to an unexplained illness in one participant.

The pause comes around a month after AstraZeneca Plc also suspended trials of its experimental coronavirus vaccine - which uses a similar technology - due to a participant falling ill. That trial remains on pause.

U.S.-based J&J, whose vaccine effort is among the high profile attempts to fight the coronavirus pandemic, said on Monday the illness was being reviewed by an independent data and safety monitoring board as well as its own clinical and safety team. The data board is then required to submit its findings to the U.S. Food and Drug administration before the study can be restarted.

Mathai Mammen, head of research & development at J&J's drugs business, said the company informed the safety board about the ill trial participant on Sunday. The board has asked for more information, he said, adding that the company is collecting information to answer its questions.


Read more here : https://www.medscape.com/viewarticle/939028?src=mkm_covid_update_201014_mscpedit_&uac=218819SG&impID=2619934&faf=1

1 view0 comments

Recent Posts

See All

Comments


bottom of page